Literature DB >> 20871636

Hypertension: Is there a dark side to thiazide therapy for hypertension?

Takahiko Nakagawa, Richard J Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20871636     DOI： 10.1038/nrneph.2010.114

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Authors:  George L Bakris; Pantelis A Sarafidis; Matthew R Weir; Björn Dahlöf; Bertram Pitt; Kenneth Jamerson; Eric J Velazquez; Linda Staikos-Byrne; Roxzana Y Kelly; Victor Shi; Yann-Tong Chiang; Michael A Weber
Journal:  Lancet       Date:  2010-02-18       Impact factor: 79.321

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Thiazide treatment of rats provokes apoptosis in distal tubule cells.

Authors:  J Loffing; D Loffing-Cueni; I Hegyi; M R Kaplan; S C Hebert; M Le Hir; B Kaissling
Journal:  Kidney Int       Date:  1996-10       Impact factor: 10.612

4.  Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis.

Authors:  Ralph G Hawkins; Mark C Houston
Journal:  Am J Hypertens       Date:  2005-06       Impact factor: 2.689

5.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

6.  Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia.

Authors:  S Reungjui; H Hu; W Mu; C A Roncal; B P Croker; J M Patel; T Nakagawa; T Srinivas; K Byer; J Simoni; D Wesson; V Sitprija; R J Johnson
Journal:  Kidney Int       Date:  2007-10-10       Impact factor: 10.612

7.  Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

Authors:  Lars H Lindholm; Mats Persson; Petar Alaupovic; Bo Carlberg; Anders Svensson; Ola Samuelsson
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

8.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

9.  Thiazide diuretics exacerbate fructose-induced metabolic syndrome.

Authors:  Sirirat Reungjui; Carlos A Roncal; Wei Mu; Titte R Srinivas; Dhavee Sirivongs; Richard J Johnson; Takahiko Nakagawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272
  10 in total
  1 in total

Review 1.  Which diuretic is the preferred agent for treating essential hypertension: hydrochlorothiazide or chlorthalidone?

Authors:  F Wilford Germino
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.